190 related articles for article (PubMed ID: 20053982)
1. Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.
Piña Y; Boutrid H; Murray TG; Jager MJ; Cebulla CM; Schefler A; Ly LV; Alegret A; Celdran M; Feuer W; Jockovich ME
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2671-7. PubMed ID: 20053982
[TBL] [Abstract][Full Text] [Related]
2. Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment.
Piña Y; Boutrid H; Schefler A; Dubovy S; Feuer W; Jockovich ME; Murray TG
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1020-4. PubMed ID: 18952925
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.
Jockovich ME; Bajenaru ML; Piña Y; Suarez F; Feuer W; Fini ME; Murray TG
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2476-82. PubMed ID: 17525173
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.
Bajenaru ML; Piña Y; Murray TG; Cebulla CM; Feuer W; Jockovich ME; Marin Castaño ME
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2860-4. PubMed ID: 20107171
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
[TBL] [Abstract][Full Text] [Related]
6. Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
Boutrid H; Piña Y; Cebulla CM; Feuer WJ; Lampidis TJ; Jockovich ME; Murray TG
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5537-43. PubMed ID: 19578014
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
[TBL] [Abstract][Full Text] [Related]
8. Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.
Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):8-11. PubMed ID: 15623747
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
Piña Y; Decatur C; Murray TG; Houston SK; Lopez-Cavalcante M; Hernandez E; Celdran M; Shah N; Feuer W; Lampidis T
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):996-1002. PubMed ID: 22266512
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy.
Jockovich ME; Piña Y; Alegret A; Cebulla C; Feuer W; Murray TG
Retina; 2008 Mar; 28(3 Suppl):S81-6. PubMed ID: 18317352
[TBL] [Abstract][Full Text] [Related]
11. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
Suárez F; Jockovich ME; Hernandez E; Feuer W; Parel JM; Murray TG
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3437-40. PubMed ID: 17652710
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
14. Targeting hypoxia, a novel treatment for advanced retinoblastoma.
Boutrid H; Jockovich ME; Murray TG; Piña Y; Feuer WJ; Lampidis TJ; Cebulla CM
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2799-805. PubMed ID: 18326690
[TBL] [Abstract][Full Text] [Related]
15. Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients.
Cuadrado-Vilanova M; Liu J; Paco S; Aschero R; Burgueño V; Sirab N; Pascual-Pasto G; Correa G; Balaguer-Lluna L; Castillo-Ecija H; Perez-Jaume S; Muñoz-Aznar O; Roldan M; Suñol M; Schaiquevich P; Aerts I; Doz F; Cassoux N; Lubieniecki F; Benitez-Ribas D; Lavarino C; Mora J; Chantada GL; Catala-Mora J; Radvanyi F; Carcaboso AM
J Pathol; 2022 Jul; 257(3):327-339. PubMed ID: 35254670
[TBL] [Abstract][Full Text] [Related]
16. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors.
Houston SK; Pina Y; Clarke J; Koru-Sengul T; Scott WK; Nathanson L; Schefler AC; Murray TG
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5359-68. PubMed ID: 21571674
[TBL] [Abstract][Full Text] [Related]
17. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice.
Schilling M; Besselmann M; Leonhard C; Mueller M; Ringelstein EB; Kiefer R
Exp Neurol; 2003 Sep; 183(1):25-33. PubMed ID: 12957485
[TBL] [Abstract][Full Text] [Related]
18. Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.
Piña Y; Houston SK; Murray TG; Boutrid H; Celdran M; Feuer W; Shi W; Hernandez E; Lampidis TJ
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6149-56. PubMed ID: 20702830
[TBL] [Abstract][Full Text] [Related]
19. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule.
Hayden BH; Murray TG; Scott IU; Cicciarelli N; Hernandez E; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2000 Nov; 118(11):1549-54. PubMed ID: 11074812
[TBL] [Abstract][Full Text] [Related]
20. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.
Jockovich ME; Murray TG; Escalona-Benz E; Hernandez E; Feuer W
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1264-8. PubMed ID: 16565356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
